Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Post-Mkt 02-11 19:03:08 EST

423.93

-22.12

-4.96%

盘后421.00

-2.93-0.69%

18:08 EST

High446.83	Low422.57	Vol691.44K
Open446.83	D1 Closing446.05	Amplitude5.44%
Mkt Cap12.03B	Tradable Cap9.42B	Total Shares28.38M
T/O295.95M	T/O Rate3.11%	Tradable Shares22.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":423.93,"timestamp":1770843600000,"preClose":446.05,"halted":0,"volume":691443,"hourTrading":{"tag":"盘后","latestPrice":421,"preClose":423.93,"latestTime":"18:08 EST","volume":18400,"amount":7799986.32,"timestamp":1770851306935,"change":-2.93,"changeRate":-0.006912,"amplitude":0.015332},"delay":0,"changeRate":-0.049590853043380796,"floatShares":22220178,"shares":28381283,"eps":15.28,"marketStatus":"Post-Mkt","change":-22.12,"latestTime":"02-11 19:03:08 EST","open":446.825,"high":446.825,"low":422.565,"amount":295950623.87169,"amplitude":0.054389,"askPrice":430.35,"askSize":10,"bidPrice":421.97,"bidSize":1,"shortable":0,"etf":0,"ttmEps":15.28,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770858000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":446.05,"preHourTrading":{"tag":"盘前","latestPrice":443.61,"preClose":446.05,"latestTime":"09:29 EST","volume":1243,"amount":553833.35469,"timestamp":1770820199999,"change":-2.44,"changeRate":-0.00547,"amplitude":0.01186},"postHourTrading":{"tag":"盘后","latestPrice":421,"preClose":423.93,"latestTime":"18:08 EST","volume":18400,"amount":7799986.32,"timestamp":1770851306935,"change":-2.93,"changeRate":-0.006912,"amplitude":0.015332},"volumeRatio":1.061044,"impliedVol":0.3762,"impliedVolPercentile":0.3227},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"1108180434","title":"Stock Track | Medpace Plummets 5.04% Intraday Amid Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1108180434","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108180434?lang=en_us&edition=fundamental","pubTime":"2026-02-12 04:34","pubTimestamp":1770842079,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) saw its stock price plummet 5.04% during Wednesday's intraday trading session. The significant drop came as investors reacted to a wave of negative sentiment from Wall...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2610895487","title":"Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2610895487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610895487?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:58","pubTimestamp":1770825529,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) has an average rating of hold and mean price target of $505.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2610395348","title":"Medpace price target lowered to $539 from $555 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2610395348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610395348?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:45","pubTimestamp":1770817536,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Medpace (MEDP) to $539 from $555 and keeps a Hold rating on the shares. The firm is updating its model af...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-539-from-555-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-lowered-to-539-from-555-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2610093171","title":"Medpace Holdings Is Maintained at Market Perform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2610093171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610093171?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:57","pubTimestamp":1770811020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 06:57 ET (11:57 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","MEDP","BK4585","BK4121","BK4588"],"gpt_icon":0},{"id":"2610319089","title":"Medpace Holdings Inc : Bmo Cuts Target Price to $460 From $600","url":"https://stock-news.laohu8.com/highlight/detail?id=2610319089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610319089?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:47","pubTimestamp":1770810430,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nFWN3Z7105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065169927.USD","LU2065171402.SGD","MEDP","BK4585","BK4588","LU2065170008.USD","BK4121","LU2065171311.SGD"],"gpt_icon":0},{"id":"2610931982","title":"Medpace Holdings Inc : Barclays Cuts Target Price to $500 From $525","url":"https://stock-news.laohu8.com/highlight/detail?id=2610931982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610931982?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:43","pubTimestamp":1770810209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nFWN3Z70JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4588","MEDP","LU2065171402.SGD","LU2065169927.USD","BK4585","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2610817669","title":"U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart","url":"https://stock-news.laohu8.com/highlight/detail?id=2610817669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610817669?lang=en_us&edition=fundamental","pubTime":"2026-02-11 16:12","pubTimestamp":1770797522,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, WalmartFeb 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Coca-Cola, Rapid7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL4N3Z70HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DD","COTY","LU0154245756.USD","BL","LU1670710588.SGD","WMT","SAIA","GILD","UPST","KO","MAS","NET","ALL","DDOG","MEDP","FTV","FISV","EW","DGX","LU1221951046.USD","BLKB","LU1621767737.EUR","LU0320765646.SGD","NKTR","ICHR","MAT","WCC","LU1201861165.SGD","CAH","PROK","EVMN","KVYO","LSCC","LU0738911758.USD","INCY","WMB","PANW","RDN","MAR","RPD","HNGE","LU0238689110.USD","HAS","PRCH","ACM","LU2108987350.USD","LYFT","ECL","AEIS"],"gpt_icon":0},{"id":"2610998673","title":"Zelluna Announces Clinical Partnership With Medpace","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998673","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610998673?lang=en_us&edition=fundamental","pubTime":"2026-02-11 15:27","pubTimestamp":1770794839,"startTime":"0","endTime":"0","summary":"Feb 11 (Reuters) - Zelluna ASA ::*ANNOUNCES CLINICAL PARTNERSHIP WITH MEDPACE  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 11-FEB-202607:00:00.19 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nRSD88jCZv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4585","BK4588","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","MEDP","LU2065171402.SGD"],"gpt_icon":0},{"id":"2610985151","title":"Zelluna Selects Medpace to Run First Clinical Trial for ZIMA-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2610985151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610985151?lang=en_us&edition=fundamental","pubTime":"2026-02-11 15:00","pubTimestamp":1770793225,"startTime":"0","endTime":"0","summary":"Zelluna ASA announced the selection of Medpace as the contract research organization  to support the first-in-human clinical trial of its lead product candidate, ZI-MA4-1 . Medpace will provide comprehensive clinical development services, including clinical operations and trial management, regulatory support, data management and analysis, and pharmacovigilance. This partnership follows the submission of a Clinical Trial Application  to the MHRA and supports Zelluna's transition to a clinical-stage company as it prepares to initiate the study pending regulatory approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zelluna ASA published the original content used to generate this news brief via GlobeNewswire  on February 11, 2026, and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL8VQMyM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2065170008.USD","LU2065171402.SGD","BK4588","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU0314104364.USD","LU2065169927.USD","SG9999014013.SGD","BK4121","SG9999014021.USD","LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","LU2065171311.SGD","MEDP","SG9999014005.SGD","BK4112","NDAQ"],"gpt_icon":0},{"id":"2610608097","title":"Medpace Holdings’ Earnings Call Signals Growth Amid Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2610608097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610608097?lang=en_us&edition=fundamental","pubTime":"2026-02-11 08:23","pubTimestamp":1770769417,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc (($MEDP)) has held its Q4 earnings call. Read on for the main highlights of the call. Medpace Holdings Inc. struck an upbeat t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medpace-holdings-earnings-call-signals-growth-amid-volatility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medpace-holdings-earnings-call-signals-growth-amid-volatility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2610678121","title":"Medpace upgraded to Outperform from Neutral at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2610678121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610678121?lang=en_us&edition=fundamental","pubTime":"2026-02-11 02:50","pubTimestamp":1770749414,"startTime":"0","endTime":"0","summary":"Baird upgraded Medpace (MEDP) to Outperform from Neutral with a price target of $564, down from $658. Published first on TheFly – the ultimate sour...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-outperform-from-neutral-at-baird-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-upgraded-to-outperform-from-neutral-at-baird-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2610624171","title":"Medpace Holdings Down Over 15%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2610624171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610624171?lang=en_us&edition=fundamental","pubTime":"2026-02-11 00:02","pubTimestamp":1770739320,"startTime":"0","endTime":"0","summary":"Medpace Holdings, Inc.  is currently at $449.26, down $81.09 or 15.29%. --Would be lowest close since Aug. 8, 2025, when it closed at $434.35. --On pace for largest percent decrease since July 23, 2024, when it fell 18.27%. --Currently down two consecutive days; down 17.12% over this period. --Worst two day stretch since the two days ending Feb. 15, 2022, when it fell 20.6%. --Down 27.61% from its all-time closing high of $620.59 on Jan. 21, 2026. --Up 37.03% from 52 weeks ago , when it closed at $327.86. --Up 62.05% from its 52-week closing low of $277.23 on April 8, 2025. --Traded as low as $443.71; lowest intraday level since Aug. 11, 2025, when it hit $436.78. --Down 16.34% at today's intraday low; largest intraday percent decrease since July 23, 2024, when it fell as much as 19.13%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","BK4585","BK4121","BK4588","LU2065170008.USD","MEDP"],"gpt_icon":0},{"id":"2610621910","title":"CRO peers lower after Medpace earnings, comments on cancellations","url":"https://stock-news.laohu8.com/highlight/detail?id=2610621910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610621910?lang=en_us&edition=fundamental","pubTime":"2026-02-10 23:10","pubTimestamp":1770736213,"startTime":"0","endTime":"0","summary":"Shares of Contract Research Organizations including Icon plc (ICLR), Fortrea (FTRE) and Charles River Labs (CRL) are trading lower after peer Medpa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cro-peers-lower-after-medpace-earnings-comments-on-cancellations-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cro-peers-lower-after-medpace-earnings-comments-on-cancellations-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"1167034040","title":"Stock Track | Medpace Plummets 10.72% Intraday on Profit Margin Concerns and Guidance Disappointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1167034040","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167034040?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:42","pubTimestamp":1770734565,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) experienced a sharp intraday plummet of 10.72% during Tuesday's trading session, significantly underperforming the broader market.The clinical research organization's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2610629360","title":"Medpace says cancellations ‘widespread’ in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629360?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:25","pubTimestamp":1770733545,"startTime":"0","endTime":"0","summary":"Asked during the company’s Q4 earnings call if cancellations were “widespread or is it just maybe one big client canceling something,” executives f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-says-cancellations-widespread-in-q4-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-says-cancellations-widespread-in-q4-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","BK4588","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","MEDP","BK4585","BK4121"],"gpt_icon":0},{"id":"1176714789","title":"Stock Track | Medpace Plunges 5.16% in Pre-market on Profit Margin Concerns Despite Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1176714789","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176714789?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:00","pubTimestamp":1770728438,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) experienced a pre-market plunge of 5.16% on Tuesday.The clinical research organization's stock fell sharply despite reporting fourth-quarter revenue and earnings that...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2610646171","title":"Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610646171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610646171?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:20","pubTimestamp":1770718857,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adaptive Biotechnologies (ADPT – Research Report) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adaptive-biotechnologies-adpt-and-medpace-holdings-medp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adaptive-biotechnologies-adpt-and-medpace-holdings-medp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171311.SGD","LU0128526141.USD","LU2065169927.USD","BK4588","XLV","ADPT","BK4581","BK4585","LU2065171402.SGD","LU0029874061.USD","XBI","BK4137","MEDP","LABU","LU2065170008.USD","BK4121","HCSG"],"gpt_icon":0},{"id":"1111832237","title":"Stock Track | Medpace Plunges 5.35% on Profit Margin Concerns Despite Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1111832237","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111832237?lang=en_us&edition=fundamental","pubTime":"2026-02-10 16:36","pubTimestamp":1770712601,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) experienced a significant 24-hour decline of 5.35% during Tuesday's trading session.The clinical research organization's stock fell sharply despite reporting...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"1133452147","title":"Stock Track | Medpace Plunges 5.15% After Hours Despite Earnings Beat as Margins Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=1133452147","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133452147?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:32","pubTimestamp":1770672771,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) saw its stock drop sharply by 5.15% in after-hours trading on Monday, following the release of its fourth-quarter and full-year 2025 financial results.The clinical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MEDP"],"gpt_icon":0},{"id":"2610694096","title":"Medpace reports Q4 EPS $4.67, consensus $4.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2610694096","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610694096?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:25","pubTimestamp":1770672338,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $708.5M, consensus $690.93M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-reports-q4-eps-4-67-consensus-4-23-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-reports-q4-eps-4-67-consensus-4-23-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":-0.2154},{"period":"1month","weight":-0.2503},{"period":"3month","weight":-0.2536},{"period":"6month","weight":-0.0275},{"period":"1year","weight":0.2582},{"period":"ytd","weight":-0.2058}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.036429},{"month":3,"riseRate":0.666667,"avgChangeRate":0.000692},{"month":4,"riseRate":0.666667,"avgChangeRate":0.005652},{"month":5,"riseRate":0.444444,"avgChangeRate":0.020283},{"month":6,"riseRate":1,"avgChangeRate":0.07437},{"month":7,"riseRate":0.666667,"avgChangeRate":0.148095},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}